HuGE Literature Finder
Records
1
-
30
Brain Radiotoxicity-Related 15CAcBRT Gene Expression Signature Predicts Survival Prognosis of Glioblastoma Patients. Neuro-oncology 2022 Jul . Reyes-González Jesús, Barajas-Olmos Francisco, García-Ortiz Humberto, Magraner-Pardo Lorena, Pons Tirso, Moreno Sergio, Aguirre-Cruz Lucinda, Reyes-Abrahantes Andy, Martínez-Hernández Angélica, Contreras-Cubas Cecilia, Barrios-Payan Jorge, Ruiz-Garcia Henry J, Hernandez-Pando Rogelio, Quiñones-Hinojosa Alfredo, Orozco Lorena, Abrahantes-Pérez María Del Carm |
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta neuropathologica 2022 2 143 (3): 403-414. Pratt Drew, Abdullaev Zied, Papanicolau-Sengos Antonios, Ketchum Courtney, Panneer Selvam Pavalan, Chung Hye-Jung, Lee Ina, Raffeld Mark, Gilbert Mark R, Armstrong Terri S, Pytel Peter, Borys Ewa, Klonoski Joshua M, McCord Matthew, Horbinski Craig, Brat Daniel, Perry Arie, Solomon David, Eberhart Charles, Giannini Caterina, Quezado Martha, Aldape Kenne |
Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study. Journal of neuro-oncology 2022 1 156 (3): 625-634. Moitra Prithwijit, Chatterjee Abhishek, Kota Priti Khatri, Epari Sridhar, Patil Vijay, Dasgupta Archya, Kowtal Pradnya, Sarin Rajiv, Gupta Tejp |
The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. Frontiers in immunology 2022 13 998236. Wang Weichen, Lu Zhichao, Wang Maoyu, Liu Zongheng, Wu Bing, Yang Chengkai, Huan He, Gong Peip |
An insertion variant of MGMT disrupts a STAT1 binding site and confers susceptibility to glioma. Cancer cell international 2021 Sep 21 (1): 506. Huang Liming, Xu Wenshen, Yan Danfang, Shi Xi, You Xin, Xu Jiaqi, You Pingping, Ke Yuanyuan, Dai Li |
High-dose radiotherapy in newly diagnosed low-grade gliomas with nonmethylated O(6)-methylguanine-DNA methyltransferase. Radiation oncology (London, England) 2021 Aug 16 (1): 157. Liu Yanwei, Li Yanong, Wang Peng, Chen Li, Feng Jin, Qiu Xiaogua |
A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma. Frontiers in oncology 2021 11 771512. Feng Qinglin, Qian Cheng, Fan Shibi |
ADD3 Deletion in Glioblastoma Predicts Disease Status and Survival. Frontiers in oncology 2021 12 11 717793. Kiang Karrie Mei-Yee, Sun Stella, Leung Gilberto Ka-K |
Is There an Independent Role of TERT and NF1 in High Grade Gliomas? Translational oncology 2019 Dec 13 (2): 346-354. Razis Evangelia, Kotoula Vassiliki, Koliou Georgia-Angeliki, Papadopoulou Kyriaki, Vrettou Eleni, Giannoulatou Eleni, Tikas Ioannis, Labropoulos Stefanos V, Rigakos Georgios, Papaemmanoyil Styliani, Romanidou Ourania, Bourkoula Eugenia, Nomikos Panagiotis, Iliadis Georgios, Nasioulas George, Selviaridis Panagiotis, Polyzoidis Konstantinos, Fountzilas Geor |
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC cancer 2019 Oct 19 (1): 968. Brito Cheila, Azevedo Ana, Esteves Susana, Marques Ana Rita, Martins Carmo, Costa Ilda, Mafra Manuela, Bravo Marques José M, Roque Lúcia, Pojo Mar |
Prognostic implications of epidermal growth factor receptor variant III expression and nuclear translocation in Chinese human gliomas. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2019 Feb 31 (1): 188-202. Yang Kaiyuan, Ren Xiaohui, Tao Liyuan, Wang Peipei, Jiang Haihui, Shen Li, Zhao Yiming, Cui Yong, Li Mingxiao, Lin So |
The potential role of MGMT rs12917 polymorphism in cancer risk: an updated pooling analysis with 21010 cases and 34018 controls. Bioscience reports 2018 Sep . Sheng Zhiguo, Kang Meini, Wang H |
An intronic genetic variation of MGMT affects enhancer activity and is associated with glioma susceptibility. Cancer management and research 2018 10 3995-4003. Huang Liming, Xu Wenshen, Dai Lian, Yan Danfang, Zhang Shu, Shi |
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation. Neuro-oncology 2017 Aug . Kessler Tobias, Sahm Felix, Sadik Ahmed, Stichel Damian, Hertenstein Anne, Reifenberger Guido, Zacher Angela, Sabel Michael, Tabatabai Ghazaleh, Steinbach Joachim, Sure Ulrich, Krex Dietmar, Grosu Anca-L, Bewerunge-Hudler Melanie, Jones David, Pfister Stefan M, Weller Michael, Opitz Christiane, Bendszus Martin, von Deimling Andreas, Platten Michael, Wick Wolfga |
Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma. Clinical nuclear medicine 2017 Feb . Bosnyák Edit, Michelhaugh Sharon K, Klinger Neil V, Kamson David O, Barger Geoffrey R, Mittal Sandeep, Juhász Csa |
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. European journal of nuclear medicine and molecular imaging 2017 Jan . Lopci Egesta, Riva Marco, Olivari Laura, Raneri Fabio, Soffietti Riccardo, Piccardo Arnoldo, Bizzi Alberto, Navarria Pierina, Ascolese Anna Maria, Rudà Roberta, Fernandes Bethania, Pessina Federico, Grimaldi Marco, Simonelli Matteo, Rossi Marco, Alfieri Tommaso, Zucali Paolo Andrea, Scorsetti Marta, Bello Lorenzo, Chiti Artu |
Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2017 30 (5): 361-371. Houdova Megova M, Drábek J, Dwight Z, Trojanec R, Koudeláková V, Vrbková J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch |
The rs16906252:C>T SNP is not associated with increased overall survival or temozolomide response in a Han-Chinese glioma cohort. PloS one 2017 12 (6): e0178842. Wei Kuo-Chen, Chen Chia-Yuan, Feng Li-Ying, Huang Wei-Tzu, Chen Chia-Hua, Hsu Peng-Wei, Wang Kai, Hood Leroy E, Chen Leslie |
MGMT-Methylated Alleles Are Distributed Heterogeneously Within Glioma Samples Irrespective of IDH Status and Chromosome 10q Deletion. Journal of neuropathology and experimental neurology 2016 Jun . Fontana Laura, Tabano Silvia, Bonaparte Eleonora, Marfia Giovanni, Pesenti Chiara, Falcone Rossella, Augello Claudia, Carlessi Nicole, Silipigni Rosamaria, Guerneri Silvana, Campanella Rolando, Caroli Manuela, Maria Sirchia Silvia, Bosari Silvano, Miozzo Moni |
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009. Cancer 2016 Apr . Gramatzki Dorothee, Dehler Silvia, Rushing Elisabeth Jane, Zaugg Kathrin, Hofer Silvia, Yonekawa Yasuhiro, Bertalanffy Helmut, Valavanis Anton, Korol Dimitri, Rohrmann Sabine, Pless Miklos, Oberle Joachim, Roth Patrick, Ohgaki Hiroko, Weller Micha |
Polymorphisms in DNA Repair Gene and Susceptibility to Glioma: A Systematic Review and Meta-Analysis Based on 33 Studies with 15 SNPs in 9 Genes. Cellular and molecular neurobiology 2016 Apr . Liu Kun, Jiang Yuga |
IDH mutation is associated with higher risk of malignant transformation in low-grade glioma. Journal of neuro-oncology 2016 Jan . Leu Severina, von Felten Stefanie, Frank Stephan, Boulay Jean-Louis, Mariani Lui |
Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma. Oncology letters 2015 Dec 10 (6): 3599-3606. Franceschi Sara, Mazzanti Chiara M, Lessi Francesca, Aretini Paolo, Carbone Francesco G, LA Ferla Marco, Scatena Cristian, Ortenzi Valerio, Vannozzi Riccardo, Fanelli Giovanni, Pasqualetti Francesco, Bevilacqua Generoso, Zavaglia Katia, Naccarato Antonio |
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival. Carcinogenesis 2015 Dec . Fogli Anne, Chautard Emmanuel, Vaurs-Barrière Catherine, Pereira Bruno, Müller-Barthélémy Mélanie, Court Franck, Biau Julian, Almeida Pinto Afonso, Kémény Jean-Louis, Khalil Toufic, Karayan-Tapon Lucie, Verrelle Pierre, Costa Bruno Marques, Arnaud Philip |
TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas. Oncotarget 2015 Nov . Gao Ke, Li Gang, Qu Yiping, Wang Maode, Cui Bo, Ji Meiju, Shi Bingyin, Hou Pe |
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2015 Sep 22 (9): 1425-9. Kong Doo-Sik, Kim Hong Rye, Choi Yoon-Ra, Seol Ho Jun, Lee Jung-Il, Nam Do-Hy |
Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis. Neuro-oncology 2015 Sep 17 (9): 1231-40. Spiegl-Kreinecker Sabine, Lötsch Daniela, Ghanim Bahil, Pirker Christine, Mohr Thomas, Laaber Magdalena, Weis Serge, Olschowski Alfred, Webersinke Gerald, Pichler Josef, Berger Walt |
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide. Neuro-oncology 2015 Apr . Rapkins Robert W, Wang Fan, Nguyen HuyTram N, Cloughesy Timothy F, Lai Albert, Ha Wendy, Nowak Anna K, Hitchins Megan P, McDonald Kerrie |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: